Capital Flow Monitor · Sponsors · CIK 1986435
Abingworth Bioventures 9 LP
1001 PENNSYLVANIA AVENUE, NW, WASHINGTON, DC, 20004 · 202-729-5626
Pooled Investment Fund / Private Equity Fund · Limited Partnership· inc. DELAWARE true 2023
Fit score
—
Offering
—
Sold
$320.3M
% sold
—
Investors
29
Min investment
$0
Exemption
506(b)
Filing history
| Filed | Form | Rule | Offering | Sold | % sold | Investors | |
|---|---|---|---|---|---|---|---|
| 2025-12-19 | D/A ·current | 506(b) | — | $320.3M | — | 29 | EDGAR ↗ |
Related persons
Executive officers, directors and promoters, as filed.
- N/A ABV 9 GP LP — Promoter, Washington, DC
- N/A ABV 9 Holdings, L.L.C. — Promoter, Washington, DC
- Jeremy Anderson — Executive Officer, Washington, DC
- Robert Rosen — Executive Officer, Washington, DC
- Christina Gibbs — Executive Officer, Washington, DC
- David Lobe — Executive Officer, Washington, DC
Placement agents
- Tcg Capital Markets L.l.c. · 0 RE raises
- Asante Capital Group Advisors, Llc · 0 RE raises
Source: SEC EDGAR Form D. Self-reported by the issuer. Not investment advice.